KI9A Stock Chart & Stats
€6.15
-€0.05(-0.81%)
At close: 4:00 PM EDT
€6.15
-€0.05(-0.81%)
Day’s Range― - ―
52-Week Range€4.20 - €7.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€100.60M
Enterprise Value€72.70
Total Cash (Recent Filing)€12.41M
Total Debt (Recent Filing)€244.00K
Price to Earnings (P/E)13.3
Beta0.93
Next Earnings
Sep 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.40
Shares Outstanding20,039,026
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.95
Price to Sales (P/S)1.69
P/FCF Ratio14.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.65Price Target Upside8.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€590.27K
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNear-zero leverage and a sizable, stable equity base materially reduce refinancing and solvency risk, giving management flexibility to invest in growth, sustain dividends, or weather sector cyclicality. Strengthened ROE (~16.5%) indicates capital is being deployed effectively over the medium term.
Strong Revenue And Earnings GrowthSustained top-line expansion and rising net income reflect scalable product adoption across geographies and species. Durable revenue and earnings growth supports long-term reinvestment in R&D and commercial expansion, and underpins improved cash generation and strategic optionality.
Consistent Cash GenerationPositive and largely consistent operating cash flows, culminating in strong free cash flow, indicate the business can convert earnings into real cash. That cash supports dividends, capex and working-capital needs, enhancing resilience to cyclical input-cost swings over many quarters.
Bears Say
Cash-Flow VolatilityEpisodic negative free cash flow and periods where operating cash did not cover earnings point to working-capital sensitivity and timing risk. Such variability can constrain capex, dividends or M&A when weaker, and makes financial planning and margin sustainability less predictable over the medium term.
Margin VolatilityMaterial swings in margins across years suggest exposure to input-costs, pricing mix or competitive pressures. Margin inconsistency reduces operating leverage benefits and can limit the company’s ability to convert sales growth into stable, predictable profitability over multiple reporting periods.
Regulatory And End-Market ExposureSales depend on products allowed under regional regulations and on adoption of natural alternatives tied to antibiotic-reduction trends. Regulatory shifts or slower policy-driven adoption in key markets could structurally reduce addressable demand or require reformulation, increasing long-term execution risk.
Anpario News
KI9A FAQ
What was Anpario’s price range in the past 12 months?
Anpario lowest stock price was €4.20 and its highest was €7.00 in the past 12 months.
What is Anpario’s market cap?
Anpario’s market cap is €100.60M.
When is Anpario’s upcoming earnings report date?
Anpario’s upcoming earnings report date is Sep 16, 2026 which is in 42 days.
How were Anpario’s earnings last quarter?
Anpario released its earnings results on Mar 31, 2026. The company reported €0.278 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Anpario overvalued?
According to Wall Street analysts Anpario’s price is currently Undervalued.
Does Anpario pay dividends?
Anpario does not currently pay dividends.
What is Anpario’s EPS estimate?
Anpario’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anpario have?
Anpario has 20,039,026 shares outstanding.
What happened to Anpario’s price movement after its last earnings report?
Anpario reported an EPS of €0.278 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.546%.
Which hedge fund is a major shareholder of Anpario?
Currently, no hedge funds are holding shares in DE:KI9A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Anpario Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€6.65 (8.12% Upside)
€6.65 (8.12% Upside)
Blogger Sentiment
Bullish
DE:KI9A Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.11%
12-Months-Change
Fundamentals
Return on Equity
2.39%
Trailing 12-Months
Asset Growth
7.09%
Trailing 12-Months
Company Description
Anpario
Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products comprising water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.
KI9A Stock 12 Month Forecast
Average Price Target
€6.65
▲(8.12% Upside)